Inhibrx Biosciences Statistics
Total Valuation
INBX has a market cap or net worth of $1.82 billion. The enterprise value is $1.86 billion.
| Market Cap | 1.82B |
| Enterprise Value | 1.86B |
Important Dates
The last earnings date was Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INBX has 14.72 million shares outstanding. The number of shares has increased by 0.61% in one year.
| Current Share Class | 14.72M |
| Shares Outstanding | 14.72M |
| Shares Change (YoY) | +0.61% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 15.22% |
| Owned by Institutions (%) | 73.32% |
| Float | 8.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 286.64 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.07
| Current Ratio | 5.07 |
| Quick Ratio | 4.76 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.21 |
Financial Efficiency
Return on equity (ROE) is -1,773.60% and return on invested capital (ROIC) is -90.13%.
| Return on Equity (ROE) | -1,773.60% |
| Return on Assets (ROA) | -43.61% |
| Return on Invested Capital (ROIC) | -90.13% |
| Return on Capital Employed (ROCE) | -101.31% |
| Weighted Average Cost of Capital (WACC) | 22.08% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.26M |
| Employee Count | 110 |
| Asset Turnover | n/a |
| Inventory Turnover | 55.75 |
Taxes
In the past 12 months, INBX has paid $3,000 in taxes.
| Income Tax | 3,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +352.01% in the last 52 weeks. The beta is 3.52, so INBX's price volatility has been higher than the market average.
| Beta (5Y) | 3.52 |
| 52-Week Price Change | +352.01% |
| 50-Day Moving Average | 94.19 |
| 200-Day Moving Average | 87.78 |
| Relative Strength Index (RSI) | 73.82 |
| Average Volume (20 Days) | 271,489 |
Short Selling Information
The latest short interest is 3.22 million, so 21.85% of the outstanding shares have been sold short.
| Short Interest | 3.22M |
| Short Previous Month | 3.34M |
| Short % of Shares Out | 21.85% |
| Short % of Float | 37.22% |
| Short Ratio (days to cover) | 14.27 |
Income Statement
| Revenue | n/a |
| Gross Profit | -103.00M |
| Operating Income | -127.81M |
| Pretax Income | -138.18M |
| Net Income | -138.18M |
| EBITDA | -125.60M |
| EBIT | -127.81M |
| Earnings Per Share (EPS) | -$8.88 |
Balance Sheet
The company has $133.34 million in cash and $181.63 million in debt, with a net cash position of -$48.28 million or -$3.28 per share.
| Cash & Cash Equivalents | 133.34M |
| Total Debt | 181.63M |
| Net Cash | -48.28M |
| Net Cash Per Share | -$3.28 |
| Equity (Book Value) | -52.98M |
| Book Value Per Share | -3.60 |
| Working Capital | 114.15M |
Cash Flow
In the last 12 months, operating cash flow was -$131.89 million and capital expenditures -$10,000, giving a free cash flow of -$131.90 million.
| Operating Cash Flow | -131.89M |
| Capital Expenditures | -10,000 |
| Depreciation & Amortization | 2.21M |
| Net Borrowing | 74.99M |
| Free Cash Flow | -131.90M |
| FCF Per Share | -$8.96 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INBX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.61% |
| Shareholder Yield | -0.61% |
| Earnings Yield | -7.61% |
| FCF Yield | -7.26% |
Analyst Forecast
The average price target for INBX is $266.67, which is 115.32% higher than the current price. The consensus rating is "Buy".
| Price Target | $266.67 |
| Price Target Difference | 115.32% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 352.95% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
INBX has an Altman Z-Score of -1.92 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.92 |
| Piotroski F-Score | 2 |